RayLife

Based in the US, RayLife develops next-generation biowearable technology for noninvasive, continuous blood analysis, offering intelligent health monitoring solutions for a diverse consumer base. RayLife specializes in health technology, focusing on biowearables that enable continuous health monitoring. Founded by a team of technology and health enthusiasts, the company is located in the US and has reached a milestone by securing USD 200,000 in pre-seed funding from Antler in March 2025, the total amount raised to date. RayLife is at the forefront of developing a next-generation biowearable, designed to facilitate noninvasive, continuous blood analysis.

This innovative product integrates advanced technologies such as light, microchips, and artificial intelligence to create a wearable lab that offers intelligent and personalized health monitoring. The primary end use case addresses the growing demand for real-time health data, allowing users to track various health metrics seamlessly throughout the day. This technology appeals to a diverse clientele, including health-conscious individuals, athletes, and those managing chronic conditions. While specific geographical markets are not disclosed, the nature of the product suggests potential for widespread adoption in urban areas with a focus on health technology and consumer wearables.

RayLife's revenue model is anticipated to revolve around direct-to-consumer sales and subscription services. The company's flagship wearable lab product is expected to be offered through a subscription-based pricing structure, providing users with ongoing access to health data analytics and insights. In this model, customers would typically engage in an initial purchase of the device, followed by a recurring fee for continuous access to software updates and data services. Partnerships with health organizations and wellness programs may also enhance revenue opportunities, facilitating bulk purchases or collaborative health initiatives.

Overall, the revenue structure is designed to create a sustainable flow of income through a combination of direct sales and ongoing customer engagement. In March 2025, RayLife raised USD 200,000 in pre-seed funding from Antler. The company plans to utilize this funding to enhance its product development, focusing on the upcoming launch of its biowearable technology. Additionally, RayLife aims to expand into urban markets known for health technology adoption, although specific regions are not detailed.

Plans are underway to establish partnerships with health organizations to support its outreach and growth strategies.